FDA Approval for Monoclonal Antibody Treatment

BREAKING NEWS! PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
 
Watch/listen to this week’s podcast interview where Professor Nancy Klimas reveals how she has just gained FDA approval to do a properly powered and fully funded random-controlled trial to test the efficacy of Monoclonal Antibodies to treat Long COVID. This is one of the research treatments that the community has been waiting for!
 
 
If you want to be part of Professor Klimas’ research study that is exploring the efficacy of Monoclonal Antibody treatment please subscribe to the Institute for Neuro Immune Medicine’s (INIM) newsletter at this link  Where details will be posted about the recruitment process in January 2025.